Table 1 Baseline characteristics of patients stratified by the TyG index tertiles
Characteristics | Total n = 1129 | TyG index tertiles | p | ||
|---|---|---|---|---|---|
Q1(n = 376) | Q2(n = 376) | Q3(n = 377) | |||
General information | |||||
Age [median (IQR)] | 62 (55, 68) | 64 (57, 70) | 62 (55, 69) | 60 (54, 65) | < 0.001 |
Male sex [n (%)] | 805 (71.30%) | 288 (76.60%) | 265 (70.48%) | 252 (66.84%) | 0.011 |
Past medical history | |||||
Hypertension [n (%)] | 778 (68.91%) | 243 (64.63%) | 265 (70.48%) | 270 (71.62%) | 0.085 |
Diabetes [n (%)] | 335 (29.67%) | 56 (14.89%) | 90 (23.94%) | 189 (50.13%) | < 0.001 |
Stroke [n (%)] | 271 (24.00%) | 98 (26.06%) | 87 (23.14%) | 86 (22.81%) | 0.516 |
Smoking [n (%)] | 363 (32.15%) | 123 (32.71%) | 122 (32.45%) | 118 (31.30%) | 0.907 |
Drinking [n (%)] | 153 (13.55%) | 44 (11.70%) | 53 (14.10%) | 56 (14.85%) | 0.848 |
Laboratory tests | |||||
WBC, median (IQR), 109/L | 6.36 (5.17, 7.68) | 6.00 (5.00, 7.30) | 6.42 (5.14, 7.66) | 6.62 (5.43, 8.16) | < 0.001 |
Platelet, median (IQR), 109/L | 199.00 (165.00, 237.00) | 191.00 (163.00, 225.25) | 206.00 (166.00, 243.25) | 201.00 (167.00, 240.00) | 0.003 |
TC, mean (SD) mmol/L | 4.15 (1.12) | 3.80 (0.94) | 4.11 (1.01) | 4.54 (1.25) | < 0.001 |
TG, median (IQR), mmol/L | 1.40 (0.99, 1.89) | 0.90 (0.74, 1.07) | 1.48 (1.29, 1.70) | 2.19 (1.74, 2.83) | < 0.001 |
HDL, mean (SD), mmol/L | 1.02 (0.25) | 1.12 (0.26) | 1.01 (0.23) | 0.93 (0.21) | < 0.001 |
LDL, mean (SD), mmol/L | 2.55 (0.90) | 2.33 (0.80) | 2.59 (0.85) | 2.72 (0.99) | < 0.001 |
GLU, median (IQR), mmol/L | 5.61 (4.98, 6.96) | 5.02 (4.59, 5.56) | 5.59 (5.06, 6.47) | 7.37 (5.76, 9.87) | < 0.001 |
TyG index | 8.81 (8.40, 9.21) | 8.23 (8.01, 8.40) | 8.81 (8.68, 8.94) | 9.41 (9.21, 9.80) | < 0.001 |
Stenosis location | < 0.001 | ||||
No stenosis [n (%)] | 143 (12.67%) | 61 (16.22%) | 45 (11.97%) | 37 (9.81%) | |
ICAS [n (%)] | 396 (35.08%) | 126 (33.51%) | 132 (35.11%) | 138 (36.60%) | |
ECAS [n (%)] | 222 (19.66%) | 93 (24.73%) | 71 (18.88%) | 58 (15.38%) | |
Combined ICAS/ECAS [n (%)] | 368 (32.60%) | 96 (25.53%) | 128 (34.04%) | 144 (38.20%) | |
Stenosis distribution | 0.110 | ||||
No stenosis [n (%)] | 143 (12.67%) | 61 (16.22%) | 45 (11.97%) | 37 (9.81%) | |
Anterior circulation [n (%)] | 403 (35.70%) | 138 (36.70%) | 134 (35.64%) | 131 (34.75%) | |
Posterior circulation [n (%)] | 179 (15.85%) | 51 (13.56%) | 58 (15.43%) | 70 (18.57%) | |
Combined anterior/posterior circulation [n (%)] | 404 (35.78%) | 126 (33.51%) | 139 (36.97%) | 139 (36.87%) | |
Stenosis severity | 0.118 | ||||
No stenosis [n (%)] | 143 (12.67%) | 61 (16.22%) | 45 (11.97%) | 37 (9.81%) | |
Mild stenosis [n (%)] | 199 (8.77%) | 138 (36.70%) | 30 (7.98%) | 31 (8.22%) | |
Moderate stenosis [n (%)] | 139 (12.31%) | 51 (13.56%) | 46 (12.23%) | 45 (11.94%) | |
Severe stenosis [n (%)] | 748 (66.25%) | 126 (33.51%) | 255 (67.82%) | 264 (70.03%) | |
Stenosis symptom | 0.098 | ||||
No stenosis [n (%)] | 143 (12.67%) | 61 (16.22%) | 45 (11.97%) | 37 (9.81%) | |
Asymptomatic [n (%)] | 318 (28.17%) | 106 (28.19%) | 102 (27.13%) | 110 (29.18%) | |
Symptomatic [n (%)] | 668 (59.17%) | 209 (55.59%) | 229 (60.90%) | 230 (61.01%) | |